1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Legacy Technology Holdings, Inc.

Legacy Technology Holdings, Inc.

LTHO
Legacy Technology Holdings, Inc.US flagOther OTC
0.00
USD
- -
- -
1,720.00Market Cap
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
TTM
Revenue per Share
0.14
0.77
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-1.91
-0.78
-0.21
-0.01
-0.02
-0.03
-0.04
-0.05
-0.26
Free Cash Flow per Basic Share
-1.39
-0.19
- -
-0.01
- -
- -
- -
- -
-0.02
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-1.91
-1.42
-1.59
-0.01
-0.05
-0.1
-0.14
-0.19
-0.42
Tangible Book Value per Share
-1.31
-0.92
-1.11
-0.15
-0.22
-0.41
-0.45
-0.5
-0.49
Basic Weighted Avg Shares
- -
1
1
9
7
4
4
4
4
Sales/Revenue/Turnover
- -
1
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-1,040.6
-89.02
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-1
- -
- -
- -
- -
- -
- -
-1
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-1,398.01
-101.06
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
-1
-1
-1
-1
-2
-2
-2
-2
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
-1
-1
-1
-1
-2
-2
-2
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'13
Jun'13
Sep'13
ST Debt
1
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
4
4
28
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'13
Jun'13
Sep'13
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
1
1
1
ST Debt
1
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
10.91%
10.54%
Free Cash Flow
- -
- -
-76.97%
Net Income, GAAP
- -
4.68%
28.68%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
-0.01
-0.01
-0.01
- -
-0.04
2012
-0.01
-0.01
-0.01
- -
-0.05
2013
-0.03
-0.01
-0.18
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2011
- -
- -
- -
- -
- -
2012
- -
- -
- -
- -
- -
2013
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Redgie T. Green
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Address
7295 W. 62nd Ave. Arvada CO United States of America 80003
IPO Date
May 16, 2006
Website
genomics-giws.com
Similar Companies
Tien Liang BioTech Co., Ltd. (4127.TWO)
Hanall Biopharma Co.,Ltd (009420.KS)
THC Biomed Intl Ltd. (THC.CN)
Beijing Aosaikang Pharmaceutical Co., Ltd. (002755.SZ)
PT Indofarma Tbk (INAF.JK)
Ipca Laboratories Limited (IPCALAB.BO)
Business
Legacy Technology Holdings, Inc. (LTHO) develops and commercializes web-based genomic preventative medicine and medical software solutions; it also functions as an investment holding company focused on hemp and hemp-related products and technologies. The company offers advanced technology systems integrating software and hardware tailored for healthcare, manufacturing, and logistics sectors, with an emphasis on sustainability, innovation, and digital transformation to enhance operational productivity. Founded in 2012 and headquartered at 7295 W. 62nd Ave., Arvada, Colorado 80003, United States, Legacy Technology Holdings operates primarily in the healthcare technology industry, serving global business clients through strategic partnerships and a distribution network. Previously operated as a nutraceutical marketing and distribution company acquiring intellectual property and processes, the firm maintains zero reported employees and trades on OTCPK with a minimal market capitalization. No major acquisitions, funding rounds, partnerships, or product launches reported in the last 1-2 years.